Gene · 6504
Papers3,484
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,484
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications. | Cells | 2021 | 33562668 | PubTator, text mining | PubMed |
| Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response. | Cancers (Basel) | 2021 | 33557101 | PubTator, text mining | PubMed |
| Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer. | BMC Cancer | 2021 | 33549054 | PubTator, text mining | PubMed |
| Secreted factors from mouse embryonic fibroblasts maintain repopulating function of single cultured hematopoietic stem cells. | Haematologica | 2021 | 33543864 | PubTator, text mining | PubMed |
| Measles Virus as an Oncolytic Immunotherapy. | Cancers (Basel) | 2021 | 33535479 | PubTator, text mining | PubMed |
| MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum. | PLoS Pathog | 2021 | 33534834 | PubTator, text mining | PubMed |
| Hemagglutinin protein of Peste des Petits Ruminants virus (PPRV) activates the innate immune response via Toll-like receptor 2 signaling. | Virulence | 2021 | 33522421 | PubTator, text mining | PubMed |
| Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity. | Cell Rep Med | 2021 | 33521702 | PubTator, text mining | PubMed |
| Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center. | NPJ Vaccines | 2021 | 33495459 | PubTator, text mining | PubMed |
| [Type I interferon and selective permissiveness of central nervous system to measles virus infection]. | Med Sci (Paris) | 2021 | 33492214 | PubTator, text mining | PubMed |
| Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder. | Contemp Clin Trials Commun | 2021 | 33490708 | PubTator, text mining | PubMed |
| Socioeconomic Status is Globally a Prognostic Factor for Overall Survival of Multiple Myeloma Patients: Synthesis of Studies and Review of the Literature. | Mediterr J Hematol Infect Dis | 2021 | 33489045 | PubTator, text mining | PubMed |
| SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques. | Nat Commun | 2021 | 33483492 | PubTator, text mining | PubMed |
| Autoimmune experimental orchitis and chronic glomerulonephritis with end stage renal disease are controlled by Cgnz1 for susceptibility to end organ damage. | Clin Immunol | 2021 | 33482358 | PubTator, text mining | PubMed |
| Antiviral Screen against Canine Distemper Virus-Induced Membrane Fusion Activity. | Viruses | 2021 | 33477492 | PubTator, text mining | PubMed |
| Investigating the Interaction between Negative Strand RNA Viruses and Their Hosts for Enhanced Vaccine Development and Production. | Vaccines (Basel) | 2021 | 33477334 | PubTator, text mining | PubMed |
| Transcriptional and functional characterization of neonatal circulating Innate Lymphoid Cells. | Stem Cells Transl Med | 2021 | 33475258 | PubTator, text mining | PubMed |
| Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages. | Cell Res | 2021 | 33473155 | PubTator, text mining | PubMed |
| Advances in Antiviral Therapy for Subacute Sclerosing Panencephalitis. | Molecules | 2021 | 33467470 | PubTator, text mining | PubMed |
| CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma. | JCI Insight | 2021 | 33465053 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6504/papers?page=56